Results 11 to 20 of about 5,040 (223)
Евразийский Кардиологический Журнал, 2023 Background. Septal myectomy is currently the «gold» standard of surgical treatment of patients with obstructive hypertrophic cardiomyopathy. In some cases, isolated septal myectomy does not eliminate SAM-induced mitral insufficiency.
A. S. Zalesov +7 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 The triglyceride–glucose index is a valuable marker of insulin resistance. However, the predictive value of this index for postoperative atrial fibrillation in patients undergoing septal myectomy remains unclear. A total of 409 patients with hypertrophic
Zhipeng Wei +5 more
doaj +1 more source
Beating-Heart Septal Myectomy: An Innovative Approach for Hypertrophic Obstructive Cardiomyopathy. [PDF]
JACC AsiaLiu L, Li J.
europepmc +2 more sources
Journal of Cardiothoracic Surgery, 2021 Background Although septal myectomy is a standard strategy for managing patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms, so far, only a few experienced myectomy centers exist globally.
Qiang Ji +6 more
doaj +1 more source
Transaortic septal myectomy using direct septal echography [PDF]
Interactive CardioVascular and Thoracic Surgery, 2018 We applied direct septal echography in transaortic septal myectomy for left ventricular outflow tract obstruction due to hypertrophic obstructive cardiomyopathy and asymmetric septal hypertrophy. A small L-shaped probe was inserted into the right ventricle through a 2-cm incision on the right ventricular outflow tract.
Kanji, Matsuzaki +3 more
openaire +2 more sources
Transmitral Septal Myectomy [PDF]
Operative Techniques in Thoracic and Cardiovascular Surgery, 2017 In patients undergoing operative intervention for hypertrophic cardiomyopathy (HCM), intrinsic abnormalities of the mitral valve may need to be addressed at the time of septal myectomy. Advantages of a transmitral approach to septal myectomy include a panoramic view of the septum and the exposure necessary to address concomitant mitral valve pathology.
Brody Wehman, James S. Gammie
openaire +1 more source
Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
Heart Vessels and Transplantation, 2023 Hypertrophic cardiomyopathy is a common genetic heart disease characterized predominantly by non-dilated hypertrophy of the left ventricle, in the absence of other cardiac, systemic, or metabolic diseases that can cause the observed degree of hypertrophy.
Sergei A. Budagaev +7 more
doaj +1 more source
Septal myectomy after failed septal alcohol ablation [PDF]
Annals of Cardiothoracic Surgery, 2017 Despite septal myectomy remaining the gold standard septal reduction therapy for hypertrophic obstructive cardiomyopathy (HOCM), there has been a disproportionate use of alcohol septal ablation (ASA) worldwide. Absolute resolution of left ventricular outflow tract (LVOT) obstruction with ASA is not achieved in a substantial proportion of patients.
Eduard, Quintana +3 more
openaire +2 more sources
JTCVS Open, 2023 Background: Septal reduction therapy via septal myectomy or a modified Konno procedure is the mainstay of therapy for drug-refractory obstructive hypertrophic cardiomyopathy (HCM), although outcomes data on septal myectomy in pediatric patients are ...
Stephanie N. Nguyen, MD +6 more
doaj +1 more source
JTCVS Techniques, 2022 Objective: Some patients with obstructive hypertrophic cardiomyopathy may remain limited after surgical relief of the subaortic obstruction. In this report, we describe experience in surgical management of patients with advanced diastolic heart failure ...
Daokun Sun, MD, MPH +5 more
doaj +1 more source